Retour
Prix Urogen Pharma Ltd (URGN)
Graphique du cours de l'action URGN
URGN Gagner
Urogen Pharma Ltd
$18.8
-3.78%
$-0.73
À la fermeture : Jan 16, 16:00:00 GMT-5
$18.8
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$19.54
Prix d'ouverture
$19.64
Plage de la journée
$18.66 - $20.15
Plage de 52 semaines
$3.42 - $30
Volume
1.0M
Volume moyen
998.7K
BPA (TTM)
-3.31
Rendement en dividend
--
Capitalisation boursière
$880.0M
Qu’est-ce que URGN ?
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. The firm is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved